
Spotlight Medical produces clinical-grade AI diagnostic tests that help clinicians select more effective cancer treatments for individual patients. The company develops evidence-driven, explainable machine learning algorithms trained on large clinical datasets and validated through rigorous clinical studies. Its products are positioned as oncology diagnostics and precision medicine tools for hospitals, pathology labs, and oncology practices. Spotlight Medical emphasizes clinical validation and physician collaboration to ensure test results are actionable within clinical decision workflows.

Spotlight Medical produces clinical-grade AI diagnostic tests that help clinicians select more effective cancer treatments for individual patients. The company develops evidence-driven, explainable machine learning algorithms trained on large clinical datasets and validated through rigorous clinical studies. Its products are positioned as oncology diagnostics and precision medicine tools for hospitals, pathology labs, and oncology practices. Spotlight Medical emphasizes clinical validation and physician collaboration to ensure test results are actionable within clinical decision workflows.
Headquarters: Paris, France (also lists an office in Boston, MA)
Founded: 2024 (spin-off from Institut Curie, launched June 27, 2024)
Product: Clinical-grade AI diagnostic tests for oncology / precision medicine
Seed funding: €6.2M announced July 12, 2024
Lead investors: Kurma Partners; Heal Capital
Oncology diagnostics; precision medicine for cancer treatment selection
2024
Biotechnology
€6.2M
Announced in company press release
“Kurma Partners; Heal Capital”